This commentary delves into the evolving landscape of cancer incidence and mortality in Costa Rica, presenting a comprehensive analysis of the data. Key findings reveal a concerning upward trajectory in cancer incidence rates, placing Costa Rica at the forefront within Central America. While prostate cancer and breast cancer dominate, disparities emerge when scrutinizing gender-specific trends. Notably, stomach and cervical cancers show declines, potentially attributed to targeted interventions. However, colorectal and liver cancers witness mortality increases, necessitating strategic responses. Geographical disparities persist across provinces, highlighting the need for equitable healthcare access. In conclusion, this commentary underscores the urgency of addressing the burgeoning cancer burden in Costa Rica, calling for evidence-based interventions and collaborative efforts on a global scale.
References
[1]
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
[2]
Ward, E., DeSantis, C., Robbins, A., Kohler, B. and Jemal, A. (2014) Childhood and Adolescent Cancer Statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 83-103. https://doi.org/10.3322/caac.21219
[3]
Makarova-Rusher, O.V., Altekruse, S.F., McNeel, T.S., Ulahannan, S., Duffy, A.G. and Graubard, B.I. (2016) Population Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States. Cancer, 122, 1757-1765. https://doi.org/10.1002/cncr.29971
[4]
Alejandro, C., Percy, G. and Jack, M. (2023) Epidemiological Patterns of Common Cancers in Costa Rica: An Overview up to 2020. Open Journal of Social Sciences, 11, 500-517. https://doi.org/10.4236/jss.2023.116033
[5]
Guerrero-López, C.M., Molina, M.S., Martínez-López, A., Villarreal-Garza, C., Ancer-Rodríguez, J. and Ocampo-Candiani, J. (2013) Trends in Skin Cancer Incidence in Monterrey, Mexico. Dermatology Practical & Conceptual, 3, 11-16.
[6]
Herrero, R., Quint, W., Hildesheim, A., et al. (2015) Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLOS ONE, 10, e0139156.